Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos.
Open Access
- 1 January 2003
- journal article
- clinical trial
- Published by Wiley in Tropical Medicine & International Health
- Vol. 8 (1) , 19-24
- https://doi.org/10.1046/j.1365-3156.2003.00977.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?Trends in Parasitology, 2001
- Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimensPaediatrics and International Child Health, 2001
- Plasmodium falciparumMalaria in Laos: Chloroquine Treatment Outcome and Predictive Value of Molecular MarkersThe Journal of Infectious Diseases, 2001
- Chloroquine or amodiaquine with sulfadoxine-pyrimethamine treatment for uncomplicated malaria a systematic review combined as aPathogens and Global Health, 1998
- Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malariaThe Lancet, 1993
- Antimalarial drug resistance: the pace quickensJournal of Antimicrobial Chemotherapy, 1992
- Mefloquine-resistant falciparum malaria on the Thai-Burmese borderThe Lancet, 1991
- DRUG THERAPY FOR PLASMODIUM FALCIPARUM MALARIA RESISTANT TO PYRIMETHAMINE-SULFADOXINE (FANSIDAR)The Lancet, 1981
- CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN THAILANDThe Lancet, 1965